Kiora Pharmaceuticals (KPRX) Other Gross PP&E Adjustments (2016 - 2025)
Kiora Pharmaceuticals' Other Gross PP&E Adjustments history spans 11 years, with the latest figure at -$434099.0 for Q4 2025.
- For Q4 2025, Other Gross PP&E Adjustments rose 52.95% year-over-year to -$434099.0; the TTM value through Dec 2025 reached -$434099.0, up 52.95%, while the annual FY2025 figure was -$434099.0, 52.95% up from the prior year.
- Other Gross PP&E Adjustments reached -$434099.0 in Q4 2025 per KPRX's latest filing, down from -$376785.0 in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of -$87544.0 in Q3 2023 to a low of -$922612.0 in Q4 2024.
- Average Other Gross PP&E Adjustments over 5 years is -$408501.8, with a median of -$376785.0 recorded in 2025.
- Peak YoY movement for Other Gross PP&E Adjustments: plummeted 1809.67% in 2021, then surged 85.16% in 2023.
- A 5-year view of Other Gross PP&E Adjustments shows it stood at -$857712.0 in 2021, then soared by 31.21% to -$590061.0 in 2022, then crashed by 48.61% to -$876903.0 in 2023, then dropped by 5.21% to -$922612.0 in 2024, then surged by 52.95% to -$434099.0 in 2025.
- Per Business Quant, the three most recent readings for KPRX's Other Gross PP&E Adjustments are -$434099.0 (Q4 2025), -$376785.0 (Q3 2025), and -$447127.0 (Q2 2025).